Sorry, you need to enable JavaScript to visit this website.

Help you patients 
improve their
glycemic outcomes

Lead the way with the industry-leading CGM

Request a Sample

 

The Dexcom G7 Sensor is waterproof and may be submerged under eight 
feet of water for up to 24 hours without failure when properly installed. 

Dexcom G7 user swimming
Lower A1C Icon

More clinically proven outcomes than any other brand2 -proven to reduce A1C, hyper and hypoglycemia and increase time in range.3-7

Accuracy Icon

Trust the most accurate CGM1,2 available to empower patients to make more confident diabetes decisions and achieve optimal results.

Reduces Hypoglycemia Icon

The Only CGM with a predictive Urgent Low Soon alert‡ providing your patients peace of mind,8 warning of severe hypoglycemia before it happens.

For pharmacists

Access practical tools and resources to support your patients

 

Get Started

Dexcom G7

Request a sample today

Complete this form and see how Dexcom G7 can help your patients with type 1 or type 2 diabetes improve their outcomes.

Dexcom G7

Request a Sample

It's easy to introduce your diabetes patients to the power of Dexcom rtCGM with a FREE 10-day sample. Patients must have a compatible smart device (sold separately): dexcom.com/compatibility.
 
Fields marked with an * are required. You may choose to provide the optional information to help us assign the appropriate representative to assist you with your inquiry.
 
 

A response will not be provided for inquiries from outside of Canada.
Please see dexcom.com for information on our consumer products.
*Stay up-to-date with Dexcom
Would you like to stay up-to-date with Dexcom products, educational events and news via email?
By choosing to opt-in, you are granting DexCom, Inc. and Dexcom Canada, Co. (together "Dexcom")permission to process the personal data you have provided so that we may send you additional information and communications by email related to Dexcom products from time-to-time. You may opt-out of these solicitations at any time by selecting the unsubscribe link at the bottom of any email or by contacting us by email at [email protected] or by mail at the address listed in Contact Us, and you may opt-in again through one of those contacts. Dexcom respects the privacy and confidentiality of your personal information. We will not share your personal information with any third-parties, except as otherwise noted in our Privacy Policy.
LBL-1004197 Rev001

 

CGM = continuous glucose monitoring.
* Based on a survey of Canadian endocrinologists (n=41). 
† Based on commercially available CGM systems as of May 1, 2025. 
‡ Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes.  

1 dQ&A, Dexcom Canadian Endos Report Wave 1 2024. 
2 Dexcom, Data on file, 2025. 
3 Beck RW, et al. JAMA. 2017;317(4):371-378. 
4 Beck RW, et al. Ann Intern Med. 2017;167(6) 365-374. 
5 Martens T, et al. JAMA. 2021;325(22):2262-2272. 
6 Leffel LM, et al. JAMA. 2020;323(23):2388-2396. 
7 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 
8 Dexcom G7 User Guide. 

Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries.© 2025 Dexcom Canada, Co. All rights reserved. MAT-8255 Vl.0